About Hartlon
Hartlon is a company based in Wilmington (United States) founded in 2012. It operates as a B2B. Hartlon offers products and services including Resorbable Vascular Stent and Drug-Eluting Stent. Hartlon operates in a competitive market with competitors including REVA Medical and Japan Medical Device Technology, among others.
- Headquarter Wilmington, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hartlon Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hartlon
Hartlon offers a comprehensive portfolio of products and services, including Resorbable Vascular Stent and Drug-Eluting Stent. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides temporary support and drug delivery for artery disease treatment.
Delivers embedded substances to promote arterial healing and resorption.
Funding Insights of Hartlon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Hartlon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Hartlon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hartlon Comparisons
Competitors of Hartlon
Hartlon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as REVA Medical and Japan Medical Device Technology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Bioresorbable drug-eluting stents are developed for arterial restoration.
|
|
| domain | founded_year | HQ Location |
Developer of magnesium alloy stents for heart disease treatment
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Hartlon
When was Hartlon founded?
Hartlon was founded in 2012.
Where is Hartlon located?
Hartlon is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
What does Hartlon do?
HARTLON focuses on creating resorbable vascular stents that provide temporary radial support and controlled drug release to treat artery diseases. These multilayer devices promote healing by delivering therapeutics and fully dissolve afterward, leaving the artery natural. Based in Newark, Delaware, United States, the company engages in medical technology innovation for cardiovascular health, emphasizing safe and effective solutions without specific client details.
Who are the top competitors of Hartlon?
Hartlon's top competitors include REVA Medical and Japan Medical Device Technology.
What products or services does Hartlon offer?
Hartlon offers Resorbable Vascular Stent and Drug-Eluting Stent.